Description
The anti-OR9Q2 (FIDCYLLAI) TCR Jurkat cell line is a stable cell line made from the anti-OR9Q2 TCR lentivirus. The recombinant Jurkat T cell was designed to predict the MOA of OR9Q2-TCR, measure the OR9Q2-TCR specificity and screen target cells expressing OR9Q2. And the product can be used to treat cytomegalovirus infection